Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanjivani Paranteral Ltd informed BSE about two decisions approved by shareholders at its 31st Annual General Meeting on September 26, 2025. M/s. HD and Associates, a practicing company secretary firm and ICSI peer-reviewed entity, has been appointed as the Secretarial Auditor for a 5-year term starting FY 2025-26. Separately, Mr. Ashwani A. Khemka (DIN: 0337118) has been re-appointed as Managing Director for a fresh 5-year term from August 1, 2025 to July 31, 2030. Mr. Khemka is a BA graduate with over 30 years of experience in the pharmaceutical sector and is the father of existing Executive Director Mr. Srivardhan Ashwani Khemka. The filing also confirms that Mr. Khemka is not debarred from holding a director position by any SEBI order.
This is a routine governance update with no negative triggers. The MD re-appointment ensures leadership continuity, while the new secretarial auditor appointment is standard regulatory compliance. No material impact on the stock is expected from these disclosures.